Literature DB >> 29857136

Gastric emptying and intestinal appearance of nonabsorbable drugs phenol red and paromomycin in human subjects: A multi-compartment stomach approach.

Paulo Paixão1, Marival Bermejo2, Bart Hens3, Yasuhiro Tsume4, Joseph Dickens5, Kerby Shedden5, Niloufar Salehi6, Mark J Koenigsknecht4, Jason R Baker7, William L Hasler7, Robert Lionberger8, Jianghong Fan8, Jeffrey Wysocki4, Bo Wen4, Allen Lee7, Ann Frances4, Gregory E Amidon4, Alex Yu4, Gail Benninghoff4, Raimar Löbenberg9, Arjang Talattof4, Duxin Sun4, Gordon L Amidon10.   

Abstract

The goal of this study was to create a mass transport model (MTM) model for gastric emptying and upper gastrointestinal (GI) appearance that can capture the in vivo concentration-time profiles of the nonabsorbable drug phenol red in solution in the stomach and upper small intestine by direct luminal measurement while simultaneously recording the contractile activity (motility) via manometry. We advanced from a one-compartmental design of the stomach to a much more appropriate, multi-compartmental 'mixing tank' gastric model that reflects drug distribution along the different regions of the stomach as a consequence of randomly dosing relative to the different contractile phases of the migrating motor complex (MMC). To capture the intraluminal phenol red concentrations in the different segments of the GI tract both in fasted and fed state conditions, it was essential to include a bypass flow compartment ('magenstrasse') to facilitate the transport of the phenol red solution directly to the duodenum (fasted state) or antrum (fed state). The fasted and fed state models were validated with external reference data from an independent aspiration study using another nonabsorbable marker (paromomycin). These results will be essential for the development and optimization of computational programs for GI simulation and absorption prediction, providing a realistic gastric physiologically-based pharmacokinetic (PBPK) model based on direct measurement of gastric concentrations of the drug in the stomach.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aspiration/motility study; Bioavailability; Bioequivalence; Gastrointestinal; Gastrointestinal mass transport model; Human gastric emptying; In vivo dissolution; Nonabsorbable marker; Oral absorption; Paromomycin; Phenol red

Mesh:

Substances:

Year:  2018        PMID: 29857136      PMCID: PMC8883359          DOI: 10.1016/j.ejpb.2018.05.033

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  40 in total

1.  Regional gastrointestinal transit and pH studied in 215 healthy volunteers using the wireless motility capsule: influence of age, gender, study country and testing protocol.

Authors:  Y T Wang; S D Mohammed; A D Farmer; D Wang; N Zarate; A R Hobson; P M Hellström; J R Semler; B Kuo; S S Rao; W L Hasler; M Camilleri; S M Scott
Journal:  Aliment Pharmacol Ther       Date:  2015-07-29       Impact factor: 8.171

2.  Gastrointestinal transfer: in vivo evaluation and implementation in in vitro and in silico predictive tools.

Authors:  Bart Hens; Joachim Brouwers; Bart Anneveld; Maura Corsetti; Mira Symillides; Maria Vertzoni; Christos Reppas; David B Turner; Patrick Augustijns
Journal:  Eur J Pharm Sci       Date:  2014-07-23       Impact factor: 4.384

3.  In Vivo Predictive Dissolution (IPD) and Biopharmaceutical Modeling and Simulation: Future Use of Modern Approaches and Methodologies in a Regulatory Context.

Authors:  H Lennernäs; A Lindahl; A Van Peer; C Ollier; T Flanagan; R Lionberger; A Nordmark; S Yamashita; L Yu; G L Amidon; V Fischer; E Sjögren; P Zane; M McAllister; B Abrahamsson
Journal:  Mol Pharm       Date:  2017-03-01       Impact factor: 4.939

Review 4.  Exploring gastrointestinal variables affecting drug and formulation behavior: Methodologies, challenges and opportunities.

Authors:  Bart Hens; Maura Corsetti; Robin Spiller; Luca Marciani; Tim Vanuytsel; Jan Tack; Arjang Talattof; Gordon L Amidon; Mirko Koziolek; Werner Weitschies; Clive G Wilson; Roelof J Bennink; Joachim Brouwers; Patrick Augustijns
Journal:  Int J Pharm       Date:  2016-11-30       Impact factor: 5.875

5.  Effect of vehicle viscosity and an anticholinergic agent on bioavailability of a poorly absorbed drug (phenolsulfonphthalein) in man.

Authors:  J J Ashley; G Levy
Journal:  J Pharm Sci       Date:  1973-04       Impact factor: 3.534

6.  [Studies on the gastric emptying related to the types of stomach forms in healthy subjects].

Authors:  T Kanaizumi
Journal:  Nihon Heikatsukin Gakkai Zasshi       Date:  1984-04

7.  Exploring the link between gastric motility and intragastric drug distribution in man.

Authors:  Jens Van Den Abeele; Joachim Brouwers; Jan Tack; Patrick Augustijns
Journal:  Eur J Pharm Biopharm       Date:  2016-11-16       Impact factor: 5.571

8.  The Evaluation of In Vitro Drug Dissolution of Commercially Available Oral Dosage Forms for Itraconazole in Gastrointestinal Simulator With Biorelevant Media.

Authors:  Kazuki Matsui; Yasuhiro Tsume; Gregory E Amidon; Gordon L Amidon
Journal:  J Pharm Sci       Date:  2016-03-25       Impact factor: 3.534

Review 9.  Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo.

Authors:  H Lennernäs; L Aarons; P Augustijns; S Beato; M Bolger; K Box; M Brewster; J Butler; J Dressman; R Holm; K Julia Frank; R Kendall; P Langguth; J Sydor; A Lindahl; M McAllister; U Muenster; A Müllertz; K Ojala; X Pepin; C Reppas; A Rostami-Hodjegan; M Verwei; W Weitschies; C Wilson; C Karlsson; B Abrahamsson
Journal:  Eur J Pharm Sci       Date:  2013-11-01       Impact factor: 4.384

10.  Anatomical classification of the shape and topography of the stomach.

Authors:  Franciszek Burdan; Ingrid Rozylo-Kalinowska; Justyna Szumilo; Krzysztof Zinkiewicz; Wojciech Dworzanski; Witold Krupski; Andrzej Dabrowski
Journal:  Surg Radiol Anat       Date:  2011-11-06       Impact factor: 1.246

View more
  6 in total

1.  "Development of Fixed Dose Combination Products" Workshop Report: Considerations of Gastrointestinal Physiology and Overall Development Strategy.

Authors:  Bart Hens; Maura Corsetti; Marival Bermejo; Raimar Löbenberg; Pablo M González; Amitava Mitra; Divyakant Desai; Dakshina Murthy Chilukuri; Alexis Aceituno
Journal:  AAPS J       Date:  2019-06-06       Impact factor: 4.009

2.  Understanding In Vivo Dissolution of Immediate Release (IR) Solid Oral Drug Products Containing Weak Acid BCS Class 2 (BCS Class 2a) Drugs.

Authors:  Min Li; Xinwen Zhang; Di Wu; Om Anand; Hansong Chen; Kimberly Raines; Lawrence Yu
Journal:  AAPS J       Date:  2021-10-26       Impact factor: 4.009

3.  A fully resolved multiphysics model of gastric peristalsis and bolus emptying in the upper gastrointestinal tract.

Authors:  Shashank Acharya; Sourav Halder; Wenjun Kou; Peter J Kahrilas; John E Pandolfino; Neelesh A Patankar
Journal:  Comput Biol Med       Date:  2021-10-15       Impact factor: 6.698

4.  A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP.

Authors:  Marival Bermejo; Bart Hens; Joseph Dickens; Deanna Mudie; Paulo Paixão; Yasuhiro Tsume; Kerby Shedden; Gordon L Amidon
Journal:  Pharmaceutics       Date:  2020-01-17       Impact factor: 6.321

5.  Measurement of fasted state gastric antral motility before and after a standard bioavailability and bioequivalence 240 mL drink of water: Validation of MRI method against concomitant perfused manometry in healthy participants.

Authors:  Khaled Heissam; Nichola Abrehart; Caroline L Hoad; Jeff Wright; Alex Menys; Kathryn Murray; Paul M Glover; Geoffrey Hebbard; Penny A Gowland; Jason Baker; William L Hasler; Robin C Spiller; Maura Corsetti; James G Brasseur; Bart Hens; Kerby Shedden; Joseph Dickens; Deanna M Mudie; Greg E Amidon; Gordon L Amidon; Luca Marciani
Journal:  PLoS One       Date:  2020-11-11       Impact factor: 3.240

6.  Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 1: Fasted State Conditions.

Authors:  Marival Bermejo; Paulo Paixão; Bart Hens; Yasuhiro Tsume; Mark J Koenigsknecht; Jason R Baker; William L Hasler; Robert Lionberger; Jianghong Fan; Joseph Dickens; Kerby Shedden; Bo Wen; Jeffrey Wysocki; Raimar Löbenberg; Allen Lee; Ann Frances; Gregory E Amidon; Alex Yu; Niloufar Salehi; Arjang Talattof; Gail Benninghoff; Duxin Sun; Gislaine Kuminek; Katie L Cavanagh; Naír Rodríguez-Hornedo; Gordon L Amidon
Journal:  Mol Pharm       Date:  2018-11-12       Impact factor: 4.939

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.